HIGHLIGHTS
- who: . and collaborators from the University of Nebraska Medical Center, United States have published the research work: Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years, in the Journal: (JOURNAL) of 23/Dec/2021
- what: RhsACE2 has been successfully applied to COVID-19 patients (Zoufaly et_al, 2020) and a number of variations of this approach have been described. Despite some methodologic caveats about the platform design of RECOVERY (Normand, 2021), this trial provides clear evidence that treatment with 6 mg of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.